Progenics Pharmaceuticals Inc. (PGNX) - NASDAQ
From other sites
Company Description
Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for the treatment of cancer. Its products are therapeutic agents, which are designed to target cancer and imaging agents, which enables clinicians and patients to visualize and manage their disease. The... More
Sector: Healthcare
Industry: Biotechnology
Country: United States